Publications by authors named "Mikolaj Bartoszkiewicz"

Breast cancer is the most commonly diagnosed cancer worldwide and the fifth leading cause of cancer death. In 2020, there were 2.3 million new cases, and 685,000 women died from it.

View Article and Find Full Text PDF

Cancer is the second leading cause of death worldwide, after cardiovascular diseases. Increasing patients' awareness and providing easier access to public information result in greater interest in alternative anticancer or unproven supportive therapies. Fear of cancer and limited trust in the treating physician are also important reasons leading patients to seek these methods.

View Article and Find Full Text PDF
Article Synopsis
  • - The COVID-19 pandemic coinciding with flu season could strain healthcare systems, complicate respiratory disease diagnoses, and worsen patient outcomes.
  • - A study surveyed 236 cancer patients about their vaccination decisions regarding seasonal influenza during the pandemic, revealing that most had never been vaccinated, yet nearly 25% expressed interest in getting vaccinated due to COVID-19 concerns.
  • - To improve flu vaccination rates among cancer patients, efforts should be made to raise awareness and interest, especially given the pandemic's impact on their health perceptions.
View Article and Find Full Text PDF

Background: The initial approval of the Pfizer/BioNTech and Moderna vaccines by the European Medicines Agency (EMA) and Food and Drug Administration (FDA) marked a milestone in the fight against the COVID-19 pandemic. The increased public debate about the vaccine development process and vaccine side effects has activated the anti-vaccine community, which has begun to spread conspiracy theories about vaccine safety.

Objectives: Our study is the first to investigate the awareness of Polish patients suffering from various chronic diseases, mainly cancer, about vaccination against SARS-CoV-2.

View Article and Find Full Text PDF

Background: Breast cancer is the most common cancer in women in Poland and worldwide. Due to growing morbidity and mortality, patients are looking for new therapeutic options. Clinical trials give cancer patients a chance to access innovative treatment often not available in the national healthcare system.

View Article and Find Full Text PDF